Report Detail
Global Ebola Treatment Market Professional Survey Report 2019
- RnM3803922 |
- 04 October, 2019 |
- Global |
- 103 Pages |
- QYResearch |
- Pharma & Healthcare
Ebola viral infection was first observed in The Democratic Republic of Congo (named after a river called Zaire) in 1976. Ebola is a viral disease which frequently causes lethal haemorrhagic fever in humans. The harmful consequences of Ebola viral infection are that the viruses can be used as potential biological weapon. The symptoms of Ebola viral infection include sudden onset of fever, sore throat, headaches, extreme tiredness, vomiting, skin rash, muscular pain, etc. Ebola virus causes haemorrhagic fever which may lead to internal or external bleeding. The symptoms appear anywhere from 2 to 21 days after exposure to Ebola, though the average is 8 to 10 days. Diagnostic tests are now being done by ELISA (Antigen-capture enzyme-linked immunosorbent assay), Polymerase Chain Reaction, Virus Location, IgM Elisa and Immunohistochemistry testing. Few vaccines and medical treatments for Ebola are in pipeline and due to the absence of effective treatments, the pharmaceutical companies now have big opportunities in the market globally. As per WHO, several care rehydration methods are adopted with fluid injection orally and other treatments are also taken care of which improves the survival rate. Top drug companies such as Hemispherx Biopharma, Biochryst Pharmaceuticals, Nano Vircides, Serepata Therapeutics, NewLink Genetics and Mapp Biopharmaceuticals are among the key players in the global Ebola treatment market and are conducting trials on a set of experimental drugs.
The global Ebola treatment market growth is driven by the increasing incidence rates of Ebola viral infection and Ebola outbreaks. As per WHO, U.S. & U.K. governments, availability of different treatment procedures to treat Ebola is expected to drive the Ebola viral disease market growth during the forecast period. The Ebola treatment market also includes therapies for those who already have Ebola, and vaccines to prevent the deadly virus. Various drug companies and regulators in the U.S. are taking a two-pronged approach in finding a way to treat the virus. Approval of vaccines are taking a longer time but when vaccines undergo trials, adoption and availability could be a limiting factor for global Ebola treatment market growth.
The global Ebola Treatment market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Ebola Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ebola Treatment market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Ebola Treatment in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Ebola Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Arbutus Biopharma
GlaxoSmithKline
Johnson & Johnson Services
Hemispherx Biopharma
BioCryst Pharmaceuticals
NanoViricides
NewLink Genetics
Chimerix
Sarepta Therapeutics
Mapp Biopharmaceutical
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Vaccine (Under Trials)
Drugs (Under Trials)
Segment by Application
Hospitals
Ambulatory Surgery Centres
Specialized Clinics
Army Camps (Veteran Facilities)
Table of Contents
Executive Summary
1 Industry Overview of Ebola Treatment
- 1.1 Definition of Ebola Treatment
- 1.2 Ebola Treatment Segment by Type
- 1.2.1 Global Ebola Treatment Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Vaccine (Under Trials)
- 1.2.3 Drugs (Under Trials)
- 1.3 Ebola Treatment Segment by Applications
- 1.3.1 Global Ebola Treatment Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hospitals
- 1.3.3 Ambulatory Surgery Centres
- 1.3.4 Specialized Clinics
- 1.3.5 Army Camps (Veteran Facilities)
- 1.4 Global Ebola Treatment Overall Market
- 1.4.1 Global Ebola Treatment Revenue (2014-2025)
- 1.4.2 Global Ebola Treatment Production (2014-2025)
- 1.4.3 North America Ebola Treatment Status and Prospect (2014-2025)
- 1.4.4 Europe Ebola Treatment Status and Prospect (2014-2025)
- 1.4.5 China Ebola Treatment Status and Prospect (2014-2025)
- 1.4.6 Japan Ebola Treatment Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Ebola Treatment Status and Prospect (2014-2025)
- 1.4.8 India Ebola Treatment Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Ebola Treatment
- 2.3 Manufacturing Process Analysis of Ebola Treatment
- 2.4 Industry Chain Structure of Ebola Treatment
3 Development and Manufacturing Plants Analysis of Ebola Treatment
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Ebola Treatment Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Ebola Treatment
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Ebola Treatment Production and Capacity Analysis
- 4.2 Ebola Treatment Revenue Analysis
- 4.3 Ebola Treatment Price Analysis
- 4.4 Market Concentration Degree
5 Ebola Treatment Regional Market Analysis
- 5.1 Ebola Treatment Production by Regions
- 5.1.1 Global Ebola Treatment Production by Regions
- 5.1.2 Global Ebola Treatment Revenue by Regions
- 5.2 Ebola Treatment Consumption by Regions
- 5.3 North America Ebola Treatment Market Analysis
- 5.3.1 North America Ebola Treatment Production
- 5.3.2 North America Ebola Treatment Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Ebola Treatment Import and Export
- 5.4 Europe Ebola Treatment Market Analysis
- 5.4.1 Europe Ebola Treatment Production
- 5.4.2 Europe Ebola Treatment Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Ebola Treatment Import and Export
- 5.5 China Ebola Treatment Market Analysis
- 5.5.1 China Ebola Treatment Production
- 5.5.2 China Ebola Treatment Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Ebola Treatment Import and Export
- 5.6 Japan Ebola Treatment Market Analysis
- 5.6.1 Japan Ebola Treatment Production
- 5.6.2 Japan Ebola Treatment Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Ebola Treatment Import and Export
- 5.7 Southeast Asia Ebola Treatment Market Analysis
- 5.7.1 Southeast Asia Ebola Treatment Production
- 5.7.2 Southeast Asia Ebola Treatment Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Ebola Treatment Import and Export
- 5.8 India Ebola Treatment Market Analysis
- 5.8.1 India Ebola Treatment Production
- 5.8.2 India Ebola Treatment Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Ebola Treatment Import and Export
6 Ebola Treatment Segment Market Analysis (by Type)
- 6.1 Global Ebola Treatment Production by Type
- 6.2 Global Ebola Treatment Revenue by Type
- 6.3 Ebola Treatment Price by Type
7 Ebola Treatment Segment Market Analysis (by Application)
- 7.1 Global Ebola Treatment Consumption by Application
- 7.2 Global Ebola Treatment Consumption Market Share by Application (2014-2019)
8 Ebola Treatment Major Manufacturers Analysis
- 8.1 Arbutus Biopharma
- 8.1.1 Arbutus Biopharma Ebola Treatment Production Sites and Area Served
- 8.1.2 Arbutus Biopharma Product Introduction, Application and Specification
- 8.1.3 Arbutus Biopharma Ebola Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 GlaxoSmithKline
- 8.2.1 GlaxoSmithKline Ebola Treatment Production Sites and Area Served
- 8.2.2 GlaxoSmithKline Product Introduction, Application and Specification
- 8.2.3 GlaxoSmithKline Ebola Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Johnson & Johnson Services
- 8.3.1 Johnson & Johnson Services Ebola Treatment Production Sites and Area Served
- 8.3.2 Johnson & Johnson Services Product Introduction, Application and Specification
- 8.3.3 Johnson & Johnson Services Ebola Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Hemispherx Biopharma
- 8.4.1 Hemispherx Biopharma Ebola Treatment Production Sites and Area Served
- 8.4.2 Hemispherx Biopharma Product Introduction, Application and Specification
- 8.4.3 Hemispherx Biopharma Ebola Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 BioCryst Pharmaceuticals
- 8.5.1 BioCryst Pharmaceuticals Ebola Treatment Production Sites and Area Served
- 8.5.2 BioCryst Pharmaceuticals Product Introduction, Application and Specification
- 8.5.3 BioCryst Pharmaceuticals Ebola Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 NanoViricides
- 8.6.1 NanoViricides Ebola Treatment Production Sites and Area Served
- 8.6.2 NanoViricides Product Introduction, Application and Specification
- 8.6.3 NanoViricides Ebola Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 NewLink Genetics
- 8.7.1 NewLink Genetics Ebola Treatment Production Sites and Area Served
- 8.7.2 NewLink Genetics Product Introduction, Application and Specification
- 8.7.3 NewLink Genetics Ebola Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Chimerix
- 8.8.1 Chimerix Ebola Treatment Production Sites and Area Served
- 8.8.2 Chimerix Product Introduction, Application and Specification
- 8.8.3 Chimerix Ebola Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Sarepta Therapeutics
- 8.9.1 Sarepta Therapeutics Ebola Treatment Production Sites and Area Served
- 8.9.2 Sarepta Therapeutics Product Introduction, Application and Specification
- 8.9.3 Sarepta Therapeutics Ebola Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Mapp Biopharmaceutical
- 8.10.1 Mapp Biopharmaceutical Ebola Treatment Production Sites and Area Served
- 8.10.2 Mapp Biopharmaceutical Product Introduction, Application and Specification
- 8.10.3 Mapp Biopharmaceutical Ebola Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of Ebola Treatment Market
- 9.1 Global Ebola Treatment Market Trend Analysis
- 9.1.1 Global Ebola Treatment Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Ebola Treatment Regional Market Trend
- 9.2.1 North America Ebola Treatment Forecast 2019-2025
- 9.2.2 Europe Ebola Treatment Forecast 2019-2025
- 9.2.3 China Ebola Treatment Forecast 2019-2025
- 9.2.4 Japan Ebola Treatment Forecast 2019-2025
- 9.2.5 Southeast Asia Ebola Treatment Forecast 2019-2025
- 9.2.6 India Ebola Treatment Forecast 2019-2025
- 9.3 Ebola Treatment Market Trend (Product Type)
- 9.4 Ebola Treatment Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Ebola Treatment Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Ebola Treatment. Industry analysis & Market Report on Ebola Treatment is a syndicated market report, published as Global Ebola Treatment Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Ebola Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
